Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Target Trial Emulation of Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis Among Patients With Chronic Obstructive Pulmonary Disease (TAME-CLC)

NCT07712016 is registered in ClinicalTrials.gov with Seoul National University as lead sponsor.

NCT NCT07712016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07712016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Target Trial Emulation of Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis Among Patients With Chronic Obstructive Pulmonary Disease (TAME-CLC)
Lead sponsor
Seoul National University
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2026
Completion date
June 30, 2027
Enrollment
27,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd), lung cancer (diagnosis)